首页> 美国卫生研究院文献>The Journal of Headache and Pain >Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy–2) study

【2h】

Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy–2) study

机译：Eptinezumab用于预防慢性偏头痛：疗效和安全通过24周的治疗方法3阶段34周（通过静脉内ALD403防止偏头痛和疗效-2）研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PROMISE-2 study design

机译：promise-2学习设计

著录项

期刊名称 The Journal of Headache and Pain
作者
Stephen Silberstein; Merle Diamond; Nada A. Hindiyeh; David M. Biondi; Roger Cady; Joe Hirman; Brent Allan; Susan Pederson; Barbara Schaeffler; Jeff Smith;
展开▼
作者单位

展开▼
年(卷),期 2020(21),1
年度 2020
页码 120
总页数 12
原文格式 PDF
正文语种
中图分类神经科学;神经病学;
关键词

机译：Eptinezumab;慢性偏头痛;功效;安全;

相似文献

外文文献
中文文献
专利

1. Eptinezumab for Prevention of Chronic Migraine (CM): Results of 2 Quarterly Intravenous Infusions in the Phase 3 PROMISE-2 (PRevention of Migraine via Intravenous Eptinezumab Safety and efficacy-2) Trial [J] . Lipton R. B., Goadsby P. J., Azimova J., Headache . 2018,第8期

机译：ePTinezumab用于预防慢性偏头痛（cm）：结果3阶段3季度静脉注射的结果 - 2（通过静脉内欧洲孢粉型安全和疗效-2）预防偏头痛（预防偏头痛
2. Eptinezumab Results for the Prevention of Episodic Migraine over One Year in the PROMISE-1 (PRevention of Migraine via Intravenous Eptinezumab Safety and efficacy-1) Trial [J] . Silberstein S. D., Kudrow D., Saper J., Headache . 2018,第8期

机译：Eptinezumab在诺斯-1（通过静脉内欧洲孢粉型安全和疗效-1）试验中预防一年内有一年内预防一年内的偏头痛（预防偏头痛）试验
3. Eptinezumab Treatment for Migraine Prevention Reduces Migraine Disability in Patients with Chronic Migraine: An Analysis from the PREVAIL Open-Label Safety Study [J] . Kudrow D., Berman G., Kassel E., Headache . 2019,第Suppla1期

机译：Eptinezumab治疗偏头痛预防可减少慢性偏头痛患者的偏头痛残疾：普遍开放式安全研究的分析
4. Efficacy of Gabapentin in the Prophylaxis of Intractable Chronic Migraine [C] . J.M. Lopez-Millan, J.B. Alcaniz-Folch, M. de las Mulas-Bejar International Pain Clinic . 2004

机译：加巴彭素在顽固性慢性偏头痛预防的疗效
5. Efficacy of a Gluten Free Diet to Help Relieve Migraines in Chronic Migraine Patients: A Case Series [D] . Ensor, Kristen R. 2019

机译：无麸质饮食有助于缓解慢性偏头痛患者偏头痛的疗效：案例系列
6. Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study [O] . Andrew M. Blumenfeld, Richard J. Stark, Marshall C. Freeman, 2018

机译：甲型肉毒杆菌毒素A预防慢性偏头痛的有效性和安全性的长期研究：COMPLE研究
7. Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double‐blind, placebo‐controlled study [O] . Takao Takeshima, Fumihiko Sakai, Koichi Hirata, 2021

机译：Erenumab治疗日本患者的偏头痛预防：3阶段，随机，双盲，安慰剂对照研究的疗效和安全结果

Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy–2) study

摘要

著录项

相似文献

相关主题

期刊订阅